Key facts
as of Sep 2026- Noah Medical is valued at approximately $2.0B (~$12/share) as of Sep 2026, per Private Market View’s composite mark.
- It has raised $516.8M across 4 recorded rounds; the latest was Later Stage VC ($230.0M) in Sep 2025.
- Notable investors include Hongshan Capital Group, Tiger Global Management, Aramco Ventures, SoftBank Group, AME Cloud Ventures — 19 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Noah Medical
Recorded secondary trades
No secondary trades in Noah Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Noah Medical in its N-PORT filings yet. We sweep new filings monthly.
Funding rounds
4 roundsAbout Noah Medical
Developer of robotic bronchoscopy designed for early diagnosis of lung nodules. The company offers image-integrated tomosynthesis, augmented fluoroscopy, a disposable bronchoscope with continuous vision, a compact single-cart design, and real-time navigation updates, enabling interventional pulmonologists, thoracic surgeons, and hospitals to perform minimally invasive procedures with improved lesion access and procedural efficiency.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Founded
- 2018
- Employees
- 315
- Website
- noahmed.com/
- Ownership
- Privately Held (backing)